Daniele J. Kouroupos, PA-C

Daniele Kouroupos practices at Richmond University Medical Center in Staten Island, New York, part of Richmond University Medical Center.

Daniele Kouroupos' NPI, 1548565856, was assigned on January 18, 2011. Daniele Kouroupos holds New York license 011309.

Daniele Kouroupos' primary practice is Richmond University Medical Center, at 355 Bard Avenue, Staten Island, NY 10310 in Richmond County. The practice phone is (718) 354-5047.

Daniele Kouroupos' primary practice is Richmond University Medical Center in Staten Island, New York, part of Richmond University Medical Center. The medical group on file is Amboy Medical Practice PC.

Dmand AI tracks the electronic health record (EHR) system at each site where Daniele Kouroupos practices. Vendor and product names are available with a free account.

Physician assistant is Daniele Kouroupos' primary specialty in the NPI Registry, under taxonomy code 363A00000X. Daniele Kouroupos is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Daniele Kouroupos is licensed in New York.

Dmand AI lists acute sinusitis, chronic nasal allergies, sleep apnea, swimmer's ear and tinnitus among the conditions Daniele Kouroupos treats.

CMS data shows 137 Medicare services from Daniele Kouroupos across 3 procedure codes in 2024, for 80 Medicare patients. Medicare paid $8,991 for them. Every service was in an office.

CMS counts 80 Medicare patients who saw Daniele Kouroupos in 2024. The largest group is 65 to 74, with 40 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 26% are also on Medicaid. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Daniele Kouroupos' median patient age at 42, with 52% women.

In 2024, Daniele Kouroupos wrote 469 Medicare Part D claims for 151 patients. 99% of them were for generic drugs. CMS names the drug for 366 of them, across 5 drugs with 11 or more claims each, at $7,104 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 71 out of 100 for Daniele Kouroupos for performance year 2024, reported through an alternative payment model (APM). Daniele Kouroupos accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 11 general payments to Daniele Kouroupos from 6 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $73.